elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-0D1AAEFB-9373-40D4-8829-60E0145EEF42
Q27852097-0D1AAEFB-9373-40D4-8829-60E0145EEF42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-0D1AAEFB-9373-40D4-8829-60E0145EEF42
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P1476
Q27852097-0D1AAEFB-9373-40D4-8829-60E0145EEF42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-0D1AAEFB-9373-40D4-8829-60E0145EEF42
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81e544ac2f7729c0e8e75cbc0a1868ede7082972
P1476
Multicenter phase I trial of t
......
patients with advanced cancer.
@en